BALCAO · LABORATORY ANALYTICAL INSTRUMENTS · SMALL CAP
Lifeloc Technologies, Inc. LCTC
16 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$9.0M
▲ 5.7% vs FY2024
EPS · FY25
$-0.90
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-47.8%
Net margin · FY25
-27.4%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 9.0M
Revenue, FY2025 · full 16-year series below
Revenue
Net income
The company lost 27 cents on every revenue dollar this year.
Per share
USD -0.90
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-47.8%
Return on equity, FY2025
ROE
Operating margin-13.6%
Net margin-27.4%
Return on assets-32.1%
Each USD of equity lost 48 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+7.3% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.1%
+7.3%
+0.2%
+2.6%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.00B
Shares outstanding, FY2025
Change, 5 years+12.2%
Change, 10 years+12.2%
The share count grew 12% in five years — the same company, cut into more, smaller slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 6.7M
total assets, end of FY2025
Total assetsUSD 6.7M
EquityUSD 4.1M
CashUSD 746,001.00
Gross debtUSD 1.1M
Net debtUSD 312,425.00
Current ratio5.10×
Net debt stands at 8% of equity.
History
16 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EBITDA $B
−0.0
−0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
·
0.0
0.0
0.0
0.0
0.0
·
Income tax $B
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
Net income $B
−0.0
−0.0
0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
EPS, diluted $
−0.90
−0.41
0.08
−0.19
0.27
−0.38
0.26
0.09
0.01
0.17
0.11
0.24
0.24
0.20
0.32
0.17
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−47.8
−16.7
3.3
−7.1
10.8
−14.5
9.7
3.6
0.2
7.7
5.3
12.7
14.1
13.7
27.2
16.6
Shares out B
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
64 of 64
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed